Incidental finding of an 11C-acetate PET-positive multiple myeloma

Annals of Nuclear Medicine

Volumn 24, Issue 1, 2010, Pages 41-44

  Lee, Sang Mi ^a   Kim, Tae Sung ^a   Lee, Jeong Won ^a   Kwon, Hyun Woo ^a   Kim, Yong Il ^a   Kang, Se Hun ^a   Kim, Seok Ki ^a  

^a National Cancer Center   (South Korea)

Author keywords

11C acetate; 18F fluorodeoxyglucose; Multiple myeloma; PET

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER SCINTISCANNING; CANCER SURGERY; CANCER TISSUE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG SYNTHESIS; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; TIBIA FRACTURE; BONE; INCIDENTAL FINDING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ACETATES; BONE AND BONES; CARBON; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 75049083417     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0325-6     Document Type: Article

References (19)

1. H Jadvar PS Conti 2002 Diagnostic utility of FDG PET in multiple myeloma Skeletal Radiol 31 690 694 10.1007/s00256-002-0580-2 12483429 (Pubitemid 36104567)
2. AM El-Shirbiny H Yeung M Imbriaco J Michaeli H Macapinlac SM Larson 1997 Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma J Nucl Med 38 1208 1210 1:STN:280:DyaK2szpvFShsA%3D%3D 9255151
3. EB Tirovola L Biassoni KE Britton N Kaleva V Kouykin JS Malpas 1996 The use of 99mTc-MIBI scanning in multiple myeloma Br J Cancer 74 1815 1820 1:STN:280:DyaK2s7hsFequg%3D%3D 8956799
4. MA Bredella L Steinbach G Caputo G Segall R Hawkins 2005 Value of FDG PET in the assessment of patients with multiple myeloma AJR Am J Roentgenol 184 1199 1204 15788594
5. W Cholewinski I Castellon B Raphael SI Heiba 2009 Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT Clin Nucl Med 34 1 3 10.1097/RLU.0b013e31818f45ac 19092371
6. C Nanni E Zamagni M Cavo D Rubello P Tacchetti C Pettinato, et al. 2007 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma World J Surg Oncol 5 68 10.1186/1477-7819-5-68 17584499
7. A Dankerl P Liebisch G Glatting C Friesen NM Blumstein D Kocot, et al. 2007 Multiple myeloma: molecular imaging with 11C-methionine PET/CT-initial experience Radiology 242 498 508 10.1148/radiol.2422051980 17179397 (Pubitemid 46146203)
8. D Roeda F Dollé C Crouzel 2002 An improvement of 11C acetate synthesis-non-radioactive contaminants by irradiation-induced species emanating from the 11C carbon dioxide production target Appl Radiat Isot 57 857 860 10.1016/S0969-8043(02)00224-5 1:CAS:528:DC%2BD38Xot1ent74%3D 12406629 (Pubitemid 35284221)
9. FE Lecouvet J Malghem L Michaux B Maldague A Ferrant JL Michaux, et al. 1999 Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey Br J Haematol 106 35 39 10.1046/j.1365-2141.1999.01529.x 1:STN:280:DyaK1MzntlGntg%3D%3D 10444160 (Pubitemid 29343524)
10. X Mariette AM Zagdanski A Guermazi C Bergot A Arnould J Frija, et al. 1999 Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma Br J Haematol 104 723 729 10.1046/j.1365-2141.1999.01244.x 1:STN:280:DyaK1M3gs1Knuw%3D%3D 10192431
11. R Tertti A Alanen K Remes 1995 The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine Br J Haematol 91 658 660 10.1111/j.1365-2141.1995.tb05363.x 1:STN:280:DyaK28%2FkvV2jug%3D%3D 8555070
12. 18F-FDG PET identifies high-risk myeloma J Nucl Med 43 1457 1463 12411548
13. L Mileshkin R Blum JF Seymour A Patrikeos RJ Hicks HM Prince 2004 A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma Eur J Haematol 72 32 37 10.1046/j.0902-4441.2004.00177.x 1:STN:280:DC%2BD2c%2FntlKmtQ%3D%3D 14962260 (Pubitemid 38161110)
14. 11C-acetate as PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer J Nucl Med 49 21 327 334 10.2967/jnumed.107.046672 1:CAS:528: DC%2BD1cXivVOltb0%3D 18199615 (Pubitemid 351225673)
15. T Abiko S Koizumi I Takanami 2009 Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET Clin Nucl Med 34 302 304 10.1097/RLU.0b013e31819e5242 19387210
16. H Nomori H Shibata K Uno K Iyama Y Honda R Nakashima, et al. 2008 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma J Thorac Oncol 3 1427 1432 19057268
17. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses J Nucl Med 44 213 221 12571212
18. M Yoshimoto A Waki Y Yonekura N Sadato T Murata N Omata, et al. 2001 Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells Nucl Med Biol 28 117 122 10.1016/S0969-8051(00)00195-5 1:CAS:528:DC%2BD3MXisVWnt70%3D 11295421 (Pubitemid 32276075)
19. RL Stjernholm 1967 Carbohydrate metabolism in leukocytes. VII. Metabolism of glucose, acetate, and propionate by human plasma cells J Bacteriol 93 1657 1661 1:CAS:528:DyaF2sXhtFertbY%3D 6025450